CalciMedica CALC
NASDAQ CALC
$0.57 -0.01 (-1.78%)
At close: Aug 21, 2026 · 4:00 PM EDT

CalciMedica (CALC) Change in Acquisitions & Divestments (2020 - 2026)

CalciMedica's (CALC) quarterly Change in Acquisitions & Divestments came in at $1.5 million in Q1 2026, down 72.22% YoY from $5.4 million in Q1 2025, and down 80.39% on a QoQ basis from $7.6 million in Q4 2025.

CalciMedica (CALC) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends

CalciMedica (CALC) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $1.5 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 72.22% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.6 million (down 14.43% YoY) and the FY2025 annual result came in at $25.5 million, up 3.69% from the prior year.
  • Change in Acquisitions & Divestments slipped to $1.5 million in Q1 2026, from $7.6 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $17.8 million in Q4 2022 to a low of $500000.0 in Q4 2023.
  • A 5-year average of $8.2 million and a median of $6.4 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
  • Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments slumped 97.18% — and 2024, when it surged 900.0%.
  • Tracing CALC's Change in Acquisitions & Divestments over 5 years: stood at $17.8 million in 2022, then tumbled by 97.18% to $500000.0 in 2023, then surged by 900.0% to $5.0 million in 2024, then jumped by 53.0% to $7.6 million in 2025, then sank by 80.39% to $1.5 million in 2026.
  • The last three Change in Acquisitions & Divestments figures came in at $1.5 million (Q1 2026), $7.6 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 CalciMedica 9.80 Mn -8.82 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.50 Mn
Mar 31, 2026 1.50 Mn
Dec 31, 2025 7.65 Mn
Dec 31, 2025 7.65 Mn
Sep 30, 2025 5.00 Mn
Sep 30, 2025 5.00 Mn
Jun 30, 2025 7.45 Mn
Jun 30, 2025 7.45 Mn
Mar 31, 2025 5.40 Mn
Mar 31, 2025 5.40 Mn
Dec 31, 2024 5.00 Mn
Dec 31, 2024 5.00 Mn
Sep 30, 2024 9.74 Mn
Sep 30, 2024 9.74 Mn
Jun 30, 2024 5.10 Mn
Jun 30, 2024 5.10 Mn
Mar 31, 2024 4.75 Mn
Mar 31, 2024 4.75 Mn
Dec 31, 2023 500,000.00
Dec 31, 2023 500,000.00